PK/PD Modeling of Magnesium in the Mother and Neonate

• Status: Completed
• Trial end date: 2014-10-01
• Target enrollment: 0
• Participant gender: All

Summary

Determine significant correlations between maternal serum magnesium levels, and maternal and neonatal outcomes.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Stanford University
• Treatments: Magnesium Sulfate

Criteria

Inclusion Criteria:

• Pregnant women ages 18-45 years

• Magnesium sulfate exposure for preeclampsia, tocolysis, or neuroprotection

• Neonates (male or female) born at 24-42 weeks gestation